Pilot order 4 of 7 / Checked July 19, 2026

Biotech Peptides
evidence record.

Biotech Peptides publishes exact-size product pages with public list prices, ordering controls, and seller-hosted COA, liquid-chromatography, and mass-spectrometry images for rows that pass this comparison. Its pages claim US synthesis and free USPS Priority shipping over $200; Peptide Local has not verified those claims or the represented lots.

Interpretation boundary

This seven-provider pilot measures public evidence access within a pre-existing price-tracking sample. It is not a market-wide ranking and does not establish identity, purity, quantity, sterility, safety, legality, regulatory approval, or fitness for use.

Pilot status

No active badge.

The record remains public so readers can audit the earlier score and its limits. Badge issuance is paused until a provider clears the broader independent-testing and market-qualification gate.

Submit a sourced provider correction
Complete scorecard

Seven findings, no hidden category.

Every finding now carries its own public source routes. The status describes evidence completeness within the category, not a product, provider, medical, legal, or safety verdict.

01
Strong22/25

Public document access

Each compared page exposes size-specific seller-hosted COA, liquid-chromatography, and mass-spectrometry images.

Public, product-linked, and lot-aware routes receive more credit than request-only or general testing claims.
02
Partial10/15

Laboratory and method disclosure

Public analytical images were visible for each compared size. Peptide Local did not establish laboratory independence, chain of custody, or vial identity.

Named laboratories and methods receive more credit. Seller statements remain claims unless independently established.
1 public source routeSeller homepage and catalog
03
Strong12/15

Lot and report traceability

Compared exact-size pages expose seller-hosted certificate, liquid-chromatography, and mass-spectrometry images. Laboratory independence and sample custody were not established.

Direct lot matching and current report routes receive more credit than catalog-wide or undated documents.
04
Partial10/15

Business identity and scope

The site publishes a United States comparison scope, research-use language, and exact-size product routes. This assessment does not establish licensing or regulatory status.

This checks published identity and scope, not licensing, ownership, incorporation, or regulatory approval.
1 public source routeSeller homepage and catalog
05
Partial6/10

Commercial policy clarity

Free USPS Priority shipping over $200 claimed; same-day shipping before 12 PST claimed. The lower-order rate is not stated on the compared pages.

Complete public rates and conditions receive more credit than threshold-only or checkout-only information.
1 public source routeSeller homepage and catalog
06
Limited1/10

Review evidence quality

REVIEWS.io shows 3 visible reviews, a thin sample, and very low editorial confidence. Sentiment does not affect this score.

The score reflects sample depth and source confidence, never positive sentiment, health outcomes, or product quality claims.
1 public source routeREVIEWS.io review record
07
No documented response0/10

Correction responsiveness

No provider correction exchange is included in the inaugural baseline.

The inaugural baseline awards no points until a dated provider exchange is documented. Paying, linking, or partnering cannot add points.
No documented response source
Review evidence boundary

3 visible reviews, kept separate.

The visible profile is extremely small and negative; multiple entries also promote unrelated sellers, weakening its usefulness.

Inspect REVIEWS.io source ↗
Improvement priorities

Largest current evidence gaps.

  1. 01Correction responsiveness
  2. 02Review evidence quality
  3. 03Laboratory and method disclosure

A provider response must identify the exact disputed field and supply a current public source. Private assurances cannot replace a public record.

Assessment source routesSeller homepage and catalogBiotech PeptidesBPC-157 10 mg price and documentsBiotech PeptidesTB-500 10 mg price and documentsBiotech PeptidesMOTS-c 10 mg price and documentsBiotech PeptidesTesamorelin 10 mg price and documentsBiotech PeptidesAOD-9604 5 mg price and documentsBiotech PeptidesPT-141 10 mg price and documentsBiotech PeptidesREVIEWS.io review source3 visible reviews · Very low confidence